298 related articles for article (PubMed ID: 12833458)
1. Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma.
Chua DT; Sham JS; Kwong DL; Au GK
Cancer; 2003 Jul; 98(1):74-80. PubMed ID: 12833458
[TBL] [Abstract][Full Text] [Related]
2. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
5. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
7. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
8. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma.
Xiao WW; Han F; Lu TX; Chen CY; Huang Y; Zhao C
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1070-6. PubMed ID: 19231110
[TBL] [Abstract][Full Text] [Related]
10. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
Chua DT; Nicholls JM; Sham JS; Au GK
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
[TBL] [Abstract][Full Text] [Related]
12. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of overall survival of nasopharyngeal carcinoma patients treated in ten years at a single institution.
Gokce T; Unlu I; Akcay C
J BUON; 2010; 15(1):36-42. PubMed ID: 20414925
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
[TBL] [Abstract][Full Text] [Related]
15. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the nasopharynx in young patients: a single institution experience.
Shen C; Gao Y; Xu T; Wang X; Ying H; Hu C
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):617-22. PubMed ID: 19660923
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy.
Palazzi M; Guzzo M; Tomatis S; Cerrotta A; Potepan P; Quattrone P; Cantù G
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1451-8. PubMed ID: 15590176
[TBL] [Abstract][Full Text] [Related]
18. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
[TBL] [Abstract][Full Text] [Related]
19. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
20. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
